NWM
ABBV icon

Northwest Wealth Management’s AbbVie ABBV Stock Holding History

Northwest Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
1,803
+282
+19% +$60.7K 0.06% 143
2026
Q1 		$331K Sell
1,521
-138
-8% -$30.6K 0.05% 170
2025
Q4 		$379K Sell
1,659
-97
-6% -$22.1K 0.06% 151
2025
Q3 		$407K Buy
1,756
+40
+2% +$8.15K 0.07% 124
2025
Q2 		$319K Buy
1,716
+9
+0.5% +$1.67K 0.06% 145
2025
Q1 		$358K Buy
1,707
+2
+0.1% +$389 0.07% 121
2024
Q4 		$303K Buy
1,705
+7
+0.4% +$1.29K 0.06% 123
2024
Q3 		$335K Buy
1,698
+8
+0.5% +$1.49K 0.08% 114
2024
Q2 		$290K Buy
1,690
+22
+1% +$3.64K 0.08% 122
2024
Q1 		$304K Sell
1,668
-229
-12% -$39.5K 0.08% 124
2023
Q4 		$294K Sell
1,897
-54
-3% -$7.87K 0.09% 122
2023
Q3 		$291K Sell
1,951
-339
-15% -$49.8K 0.1% 120
2023
Q2 		$309K Buy
2,290
+33
+1% +$4.84K 0.11% 112
2023
Q1 		$360K Sell
2,257
-5
-0.2% -$764 0.14% 104
2022
Q4 		$366K Buy
2,262
+158
+8% +$24.2K 0.16% 100
2022
Q3 		$282K Sell
2,104
-312
-13% -$44.8K 0.12% 115
2022
Q2 		$370K Buy
2,416
+606
+33% +$92.6K 0.16% 104
2022
Q1 		$293K Buy
+1,810
New +$263K 0.14% 108
2021
Q3 		– Sell
-3,167
Closed -$357K – 117
2021
Q2 		$357K Buy
+3,167
New +$357K 0.19% 92
2019
Q2 		– Sell
-813
Closed -$65K – 118
2019
Q1 		$65K Buy
813
+100
+14% +$8.18K 0.05% 196
2018
Q4 		$66K Hold
713
– – 0.06% 179
2018
Q3 		$67K Hold
713
– – 0.05% 191
2018
Q2 		$66K Hold
713
– – 0.05% 195
2018
Q1 		$68K Buy
+713
New +$78.3K 0.05% 189

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Northwest Wealth Management's ABBV Position: Q2 2026 in Review

Northwest Wealth Management increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $60.7K and bringing the position to 1,803 shares worth $454K. The position accounts for 0.06% of the portfolio, ranked #143.

Northwest Wealth Management first reported a position in ABBV in Q1 2018 and has held it in 24 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Northwest Wealth Management held 1,803 shares of AbbVie worth $454K as of Q2 2026.
  • Northwest Wealth Management bought 282 AbbVie shares in Q2 2026, an estimated $60.7K.
  • AbbVie made up 0.06% of Northwest Wealth Management's portfolio in Q2 2026, its #143 holding.
  • Northwest Wealth Management first reported a position in AbbVie in Q1 2018 and has held it in 24 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Northwest Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.